Human Reproduction, Vol. 17, No. 7, 1777-1782,
July 2002
© 2002 European Society of Human Reproduction and Embryology
Oocyte and embryo quality after coasting: the experience from oocyte donation
1 IVI-Madrid, Madrid, 2 Instituto Valenciano de Infertilidad (IVI) and 3 Department of Paediatricis, Obstetrics and Gynaecology, Valencia University of Medicine, Valencia, Spain
BACKGROUND: Oocyte donation provides us with an opportunity to study the clinical outcome of oocytes, retrieved from women undergoing coasting, in recipients in whom endometrial receptivity is unaltered by the coasting procedure. Thus, our aim was to describe oocyte donation outcome in donors undergoing coasting, the oocyte and embryo quality obtained from these cycles, and to determine the influence of coasting duration in the cycle outcome. METHODS: Matched-paired analysis included 15 oocyte donors with high response to ovarian stimulation and submitted to coasting and 15 oocyte donors with normal response to ovarian stimulation and not undergoing coasting. There were 38 oocyte recipients who shared oocytes from the donors under coasting and 37 from donors not undergoing coasting. RESULTS: Both groups of donors were comparable in terms of days and dose of ovarian stimulation, oocytes retrieved, metaphase II oocytes obtained, and in the appearance of ovarian hyperstimulation syndrome. Both groups of oocyte recipients were comparable in male-associated factor, pregnancy and implantation rates, as well as in embryo quality. Recipients from donors with coasting for >4 days had significantly lower implantation and pregnancy rates. CONCLUSIONS: the outcome of oocyte donation from donors undergoing coasting is not impaired, as good implantation and pregnancy rates are achieved. Embryo quality, according to our current standards, does not seem to be compromised by coasting itself. However, if coasting in oocyte donors is prolonged for >4 days there is a significant decrease in both implantation and pregnancy rates.
Key words: coasting/oocyte donation/oocyte quality/ovarian hyperstimulation syndrome
4 To whom correspondence should be addressed at: IVI-Madrid, C/ Santiago de Compostela 88, 28035 Madrid, Spain. E-mail: jgvelasco{at}ivi.es
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. L. Gustofson, J. H. Segars, and F. W. Larsen Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome Hum. Reprod., November 1, 2006; 21(11): 2830 - 2837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mansour, M. Aboulghar, G. Serour, Y. Amin, and A. M. Abou-Setta Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome Hum. Reprod., November 1, 2005; 20(11): 3167 - 3172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Garcia-Velasco and A. Pellicer Reply: coasting acts through down regulation of VEGF gene expression and protein secretion Hum. Reprod., February 1, 2005; 20(2): 575 - 576. [Full Text] [PDF]
|
|
|
|
|
|
J.A. Garcia-Velasco, A. Zuniga, A. Pacheco, R. Gomez, C. Simon, J. Remohi, and A. Pellicer Coasting acts through downregulation of VEGF gene expression and protein secretion Hum. Reprod., July 1, 2004; 19(7): 1530 - 1538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Levinsohn-Tavor, S. Friedler, M. Schachter, A. Raziel, D. Strassburger, and R. Ron-El Coasting--what is the best formula? Hum. Reprod., May 1, 2003; 18(5): 937 - 940. [Abstract] [Full Text] [PDF]
|
|